Published in J Biomed Opt on November 09, 2006
Guidelines for the management of chronic kidney disease. CMAJ (2008) 2.54
Risk equation determining unsuccessful cannulation events and failure to maturation in arteriovenous fistulas (REDUCE FTM I). J Am Soc Nephrol (2006) 2.47
Intensive hemodialysis associates with improved survival compared with conventional hemodialysis. J Am Soc Nephrol (2012) 2.15
Warfarin anticoagulation in hemodialysis patients: a systematic review of bleeding rates. Am J Kidney Dis (2007) 1.70
Increased disk size in glaucomatous eyes vs normal eyes in the Reykjavik eye study. Am J Ophthalmol (2003) 1.62
A biosynthetic alternative to human donor tissue for inducing corneal regeneration: 24-month follow-up of a phase 1 clinical study. Sci Transl Med (2010) 1.53
Radial distributions of air plants: a comparison between epiphytes and mistletoes. Ecology (2016) 1.40
Wavefront-guided correction of ocular aberrations: are phase plate and refractive surgery solutions equal? J Opt Soc Am A Opt Image Sci Vis (2005) 1.38
Cellular and nerve regeneration within a biosynthetic extracellular matrix for corneal transplantation. Proc Natl Acad Sci U S A (2003) 1.28
Cdc42GAP regulates c-Jun N-terminal kinase (JNK)-mediated apoptosis and cell number during mammalian perinatal growth. Proc Natl Acad Sci U S A (2005) 1.17
Vascular smooth muscle cell differentiation to an osteogenic phenotype involves TRPM7 modulation by magnesium. Hypertension (2010) 1.14
PEG-stabilized carbodiimide crosslinked collagen-chitosan hydrogels for corneal tissue engineering. Biomaterials (2008) 1.13
A simple, cross-linked collagen tissue substitute for corneal implantation. Invest Ophthalmol Vis Sci (2006) 1.12
Coordinated control of self-renewal and differentiation of neural stem cells by Myc and the p19ARF-p53 pathway. J Cell Biol (2008) 1.08
Recombinant human collagen for tissue engineered corneal substitutes. Biomaterials (2008) 1.08
Collagen-phosphorylcholine interpenetrating network hydrogels as corneal substitutes. Biomaterials (2008) 1.06
Warfarin and aortic valve calcification in hemodialysis patients. J Nephrol (2007) 1.01
Tissue-engineered recombinant human collagen-based corneal substitutes for implantation: performance of type I versus type III collagen. Invest Ophthalmol Vis Sci (2008) 1.00
Pilot test of the SALT mass casualty triage system. Prehosp Emerg Care (2009) 0.98
An open, interoperable, and scalable prehospital information technology network architecture. Prehosp Emerg Care (2011) 0.98
Novel O-[(11)C]methylated derivatives of candesartan as angiotensin II AT(1) receptor imaging ligands: radiosynthesis and ex vivo evaluation in rats. Bioorg Med Chem (2009) 0.95
Comparison of surgically removed cardiac valves of patients with ESRD with those of the general population. Am J Kidney Dis (2005) 0.88
Defining a monophyletic Cardinalini: a molecular perspective. Mol Phylogenet Evol (2007) 0.87
Acute renal failure and disseminated intravascular coagulation associated with rifampin in tuberculosis treatment. Int J Tuberc Lung Dis (2011) 0.87
Fluoroscopic manipulation of peritoneal dialysis catheters: outcomes and factors associated with successful manipulation. Clin J Am Soc Nephrol (2012) 0.86
Postpartum assessment of the renin angiotensin system in women with previous severe, early-onset preeclampsia. J Clin Endocrinol Metab (2011) 0.86
Correlation between refractive error, corneal power, and thickness in a large population with a wide range of ametropia. Invest Ophthalmol Vis Sci (2011) 0.86
Seeing eye to eye: the key to reducing catheter use. J Vasc Access (2011) 0.85
Regeneration of corneal cells and nerves in an implanted collagen corneal substitute. Cornea (2008) 0.85
Vascular access for intensive maintenance hemodialysis: a systematic review for a Canadian Society of Nephrology clinical practice guideline. Am J Kidney Dis (2013) 0.84
Innervated human corneal equivalents as in vitro models for nerve-target cell interactions. FASEB J (2003) 0.84
Functional innervation in tissue engineered models for in vitro study and testing purposes. Toxicol Sci (2004) 0.83
International practice patterns and factors associated with non-conventional hemodialysis utilization. BMC Nephrol (2011) 0.82
Innervation of tissue-engineered corneal implants in a porcine model: a 1-year in vivo confocal microscopy study. Invest Ophthalmol Vis Sci (2007) 0.81
Cancer screening and life expectancy of Canadian patients with kidney failure. Nephrol Dial Transplant (2002) 0.81
Advanced corneal surface ablation efficacy in myopia: changes in higher order aberrations. Can J Ophthalmol (2011) 0.80
A high serum vancomycin level is associated with lower relapse rates in coagulase-negative staphylococcal peritonitis. Perit Dial Int (2014) 0.80
Daily hemofiltration for end-stage renal disease: a feasibility and efficacy trial. Blood Purif (2004) 0.80
Innervation of tissue-engineered recombinant human collagen-based corneal substitutes: a comparative in vivo confocal microscopy study. Invest Ophthalmol Vis Sci (2008) 0.79
Left ventricular growth after 1 year of haemodialysis does not correlate with arteriovenous access flow: a prospective cohort study. Nephrol Dial Transplant (2010) 0.79
Effects of advanced surface ablations and intralase femtosecond LASIK on higher order aberrations and visual acuity outcome. Saudi J Ophthalmol (2011) 0.78
Rationale for a home dialysis virtual ward: design and implementation. BMC Nephrol (2014) 0.78
The therapeutic potential of C-peptide in kidney disease: a protocol for a systematic review and meta-analysis. Syst Rev (2014) 0.77
Accessing the access. Clin J Am Soc Nephrol (2012) 0.77
Advanced cardiac life support and defibrillation in severe hypothermic cardiac arrest. Prehosp Emerg Care (2009) 0.75
Re: "porous implant exposure: incidence, management, and morbidity". Ophthal Plast Reconstr Surg (2007) 0.75
Gabapentin-induced myopathy in 2 patients on short daily hemodialysis. Am J Kidney Dis (2005) 0.75
Design and implementation of the Canadian Kidney Disease Cohort Study (CKDCS): A prospective observational study of incident hemodialysis patients. BMC Nephrol (2011) 0.75
Allergic contact dermatitis and eosinophilia in association with a hemodialysis cannula. Am J Kidney Dis (2005) 0.75
Patentability of micro-organisms: Diamond v. Chakrabarty. Ark Law Rev (1982) 0.75
Identification of plasma antifibrin/fibrinogen antibodies in a patient with hemolytic uremic syndrome. Blood Coagul Fibrinolysis (2006) 0.75
Quantitative impact of small angle forward scatter on whole blood oximetry using a Beer-Lambert absorbance model. Analyst (2011) 0.75
High-dose hemodialysis: time for a change. Hemodial Int (2014) 0.75
Spectroscopic whole-blood indicators of end-stage renal disease and the hemodialysis treatment. Photochem Photobiol (2007) 0.75
Distinct profile of vascular progenitor attachment to extracellular matrix proteins in cancer patients. Clin Invest Med (2012) 0.75